Navigation Links
Implanted Defibrillators Boost Long-Term Survival
Date:5/14/2009

Heart patients gained an extra year of life over 8 years of follow-up, study finds,,,,

THURSDAY, May 14 (HealthDay News) --Implanted cardioverter defibrillators (ICDs) extend heart patients' lives even eight years after implantation, new research shows.

The finding was to be presented Thursday at the Heart Rhythm Society annual meeting, in Boston.

"This study proves that ICD therapy, sustained for over eight years, does in fact improve survival rates and ultimately save lives," study author Dr. Ilan Goldenberg, of the University of Rochester Medical Center, N.Y., said in a heart society news release.

In the study, the researchers tracked outcomes for more than 1,200 patients with ischemic left ventricular dysfunction who enrolled in the study in 2001.

After eight years of follow-up, 61 percent of patients without an ICD had died of any cause, compared to 45 percent of those with the implanted device. The 16 percent jump in survival equals an average gain in life span of 1.2 years over the eight-year period, the team said.

Long-term effectiveness of the devices was enhanced among patients who received some left ventricular pacing and among those who did not go on to develop heart failure, the researchers added.

More information

There's more on cardiac defibrillation at the American Heart Association.



-- E.J. Mundell



SOURCE: Heart Rhythm Society, news release, May 14, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Implanted Defibrillators Benefit Older People
2. New Guidelines Issued for Implanted Heart Devices
3. Test Spots Who Should Get Implanted Defibrillator
4. Study Stresses Importance of Availability of Automated External Defibrillators at Athletic Events
5. $3.5 Million in Reimbursements for Purchases of Automated External Defibrillators (AEDs) for Texas Schools Still Unclaimed With Deadline Approaching
6. MP3 headphones interfere with implantable defibrillators, pacemakers
7. Home Defibrillators Fail to Boost Survival Rates
8. Several methods for enhancing the functioning of defibrillators in cases of heart attack
9. Defibrillators Not Dangerous While Driving
10. Plaintiffs Obtain $240 Million Amended Settlement In Guidant Defibrillators Products Liability Litigation
11. Women Less Likely to Get Heart Defibrillators
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Implanted Defibrillators Boost Long-Term Survival
(Date:1/22/2017)... TX (PRWEB) , ... January 22, 2017 , ... ... provide slow results. Often the results of a simple test will take days to ... Any Lab Test Now offers customers direct access to their lab tests, bypassing the ...
(Date:1/21/2017)... (PRWEB) , ... January 21, 2017 , ... Phytocéane ... Indian Ocean, isolated from the rest of the world with ZANZIBAR SHOWER GEL. Inspired ... Phytocéane used key ingredients, Virgin Coconut Oil and moisturizing vegetal coral to create this ...
(Date:1/21/2017)... ... January 21, 2017 , ... The Nobel ... Dan Holtzclaw in media for its creos™ line of bone regenerative products. ... Holtzclaw in which he utilizes creos™ allo.gain™ bone graft for a variety of ...
(Date:1/20/2017)... , ... January 20, 2017 , ... Doctor C LLC, ... attended the January ECRM trade show to continue the marketing and distribution of its ... supplement, known for providing 400 percent better absorption than traditional vitamin C supplements. At ...
(Date:1/20/2017)... ... January 20, 2017 , ... Michael and Betsy Brauser celebrated 5 years ... Betsy, the clinical trial has been life-saving as she has been on the ... Betsy Brauser was diagnosed with ovarian cancer in 2009. She underwent standard chemotherapy but ...
Breaking Medicine News(10 mins):
(Date:1/21/2017)... 2017 ResMed (NYSE: RMD ), BMC ( ... Haven, Florida ) today announced they have agreed on a ... will be permitted to sell their existing products in exchange for ... payment to 3B to close the Florida ... admission of liability or wrongdoing by any party. ...
(Date:1/21/2017)... , Jan. 20, 2017 ARMO BioSciences, Inc., ... data on the Company,s lead investigational immuno-oncology drug AM0010 ... by the American Society of Clinical Oncology (ASCO), taking ... CA. "AM0010 induces the ... + T cells in the blood and tumors ...
(Date:1/21/2017)... -- Research and Markets has announced the addition of ... Route Of Administration, End User - Forecast to 2025" report ... ... a CAGR of around 7.8% over the next decade to reach ... analyzes the global markets for Advanced Drug Delivery across all the ...
Breaking Medicine Technology: